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Identity 
Other names: CAS, CTNND, KIAA0384, P120CAS, 
P120CTN, p120 
HGNC (Hugo): CTNND1 
Location: 11q12.1 




DNA contains 57419 bp composed of 21 exons, 19 of 
which are coding exons. 
Transcription 
Alternative transcription produces several distinct 
mRNAs ranging from 5676 bp to 6329 bp, transcribed 
in centromeric to telomeric orientation, with open 





This gene encodes a member of the Armadillo (Arm) 
family of proteins, which function in cell-cell adhesion 
and signal transduction, and is the prototype for a 
subfamily of proteins that includes p120-catenin 
(hereafter p120), delta-catenin, p0071, and plakophilins 
1-3 (PKP1, PKP2, PKP3). CTNND1/p120 has four 
distinct translation start codons (isoforms 1-4) and 
three alternatively spliced exons (A, B, and C), 
potentially resulting in 32 isoforms as products of 
alternative splicing. A coiled-coil domain is present in 
the extreme amino-terminus of the long-isoform 
(isoform-1), and an amino terminal phosphorylation 
domain is present in all but the shortest isoform 
(isoform-4).  
All p120 isoforms contain a central Arm domain 
consisting of nine Arm repeats. p120 has been shown t  
be post-translationally modified by phosphorylation on 
tyrosine, serine, and threonine residues, as well as by 
cleavage by the protease calpain.  
 
CTNND1/p120 gene structure. DNA of CTNND1 gene (NM_001085458.1) composed of 19 coding exons (red). Untranslated regions 
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CTNND1/p120 protein structure. p120 contains four translational start sites (1-4, arrows) and three alternatively transcribed exons A, B, 
and C (red boxes). Isoform-1 contains an amino-terminal coiled coil domain (CC), and a phosphorylation domain (PD) is present in all but 
isoform-4. All isoforms contain a central Armadillo repeat domain (gray boxes). 
 
Phosphorylation of p120 may be regulated in part via 
interactions with non-receptor tyrosine kinases, 
(including Fer, Fyn, and Yes) and protein tyrosine 
phosphatases (including PTPmu, SHP-1, and DEP-1). 
Expression 
p120 isoforms have been detected in all tissues 
examined, although cells of epithelial origin tend to 
predominantly express isoform 3, whereas motile, 
fibroblastoid cells often express isoform 1. 
Localisation 
Cell-cell junctions (bound to cadherin molecules), 
cytoplasm, and nucleus. 
Function 
CTNND1/p120 was originally identified as a substrate 
for the Src oncogene and for various receptor tyrosine 
kinases, though its most prominent role is in stabilizing 
adherens junctions. Via its Arm domain, p120 binds to 
the juxtamembrane region of the cytoplasmic tails of 
type I and II cadherins. Upon removal of p120, by 
either gene knock-out or shRNA-mediated knock-
down, adherens junction components, namely cadherin, 
beta-catenin, and alpha-catenin, are internalized an  
rapidly degraded. p120 also likely participates in the
rearrangement of the actin cytoskeleton via regulation 
of Rho family GTPases, and p120 may also influence 
gene expression via its interaction in the nucleus and
cytoplasm with the transcriptional repressor Kaiso. 
Homology 
Pan troglodytes - CTNND1; Canis lupus familiaris - 
CTNND1; Bos taurus - CTNND1; Mus musculus - 
Ctnnd1; Rattus norvegicus - Ctnnd1; Gallus gallus - 
RCJMB04_21j12; Danio rerio - LOC556726. 
Mutations 
Note 
While p120 is frequently decreased in a wide variety of 
cancers, the only mutated p120 identified to date is 
found in colonic SW48 cells. In these cells, a 
heterozygous nonsense mutation in exon 7 at 
nucleotide 1908 (C to T) yields a premature stop codon 
that truncates the protein in the third ARM repeat. 
Several other cDNA abnormalities, including deletion 
of exon 17, retention of intron 19, or retention of b th  
introns 19 and 20, were also identified in both p120 
alleles in these cells, resulting in premature stop c dons 




p120's ability to stabilize E-cadherin, a tumor 
suppressor, suggests that p120 may play a role in tumor 
and/or metastasis suppression. Indeed, p120 is often 
lost, downregulated, or mislocalized in human colon, 
breast, prostate, lung, and other carcinomas. Total p120 
knockout is embryonically lethal in mice, but 
conditional knockout studies have shown that p120 loss
in the salivary gland induces dysplasia 
indistinguishable from high-grade intraepithelial 
neoplasia, and p120 ablation in the epidermis induces 
hyperproliferation and inflammation. However, recent 
studies have also identified a requirement for p120 in 
anchorage-independent growth of both tumor cell lines 
and oncogene-transformed cell lines. Moreover, a role 
for p120 and its binding partner Kaiso in Wnt 
signaling, which is often hyperactive in colon cancer, is 
becoming increasingly evident. 
Breast cancer 
Note 
cDNA microarray analysis revealed a downregulation 
of p120 in invasive breast cancers compared to their 
respective benign control breast tissues, and 
immunohistochemical analyses of tissue samples from 
341 invasive breast cancer patients found that p120 
downregulation predicted a 3.1-fold risk in breast 
cancer death. 
Additionally, translation initiation factor eIF4GI-
enhanced translation of IRES-containing p120 mRNAs 
has been shown to promote tumor emboli formation in 
inflammatory breast cancer. 
Lung cancer 
Note 
A study of 138 patients with non-small cell lung can er 
found that p120 membrane localization was reduced 
and ectopic cytoplasmic expression was increased in 
lung cancer tissues. Abnormal p120 localization 
correlated with TNM stage and lymph node metastasis. 
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Skin cancer 
Note 
p120 was found to be altered in squamous cell 
carcinomas in humans, and conditional ablation of 
p120 in the epidermis in mice led to progressive 
development of skin neoplasias. 
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